LivingGLP1
Study S002245

Assessment of Hepatic Glucose and Fat Regulation in Overweight Adolescent Girls

Registration

Registration
NCT02157974
Acronym
APPLE
Study type
INTERVENTIONAL
Allocation
NON_RANDOMIZED
Phase
PHASE2; PHASE3
Masking
NONE
Status
COMPLETED
Enrollment
92
Start
2014-08
Primary completion
2022-12
Lead sponsor
University of Colorado, Denver
Conditions
Hepatic Steatosis; Polycystic Ovarian Syndrome; Obesity
Interventions
DRUG:Byetta 5Mcg Pen Injection
Results posted
TRUE
Individual participant data sharing
NO
Secondary identifiers
NIH:UL1TR001082; NIH:K23DK107871

Registered primary outcomes

  • Hepatic Glucose Release [Measured up to 4 months from enrollment]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.